{"id":"W2979521435","doi":"10.1182/blood.v128.22.1854.1854","title":"Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Chemoimmunotherapy; Medicine; Internal medicine; Clinical endpoint; Discontinuation; Antimetabolite; Cytarabine; Oncology; Primary central nervous system lymphoma; Methotrexate; Lymphoma; Surgery; Gastroenterology; Chemotherapy; Clinical trial; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003038013,0.0007792703,0.001726439,0.0002354627,0.0003649983,0.0009177095,0.0004899564,0.0007569863,0.0009578075],"category_scores_gemma":[0.001037869,0.0003709677,0.001522702,0.0003933483,0.0004642646,0.0002812894,0.0003195547,0.001155487,0.0002165715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008449914,"about_ca_system_score_gemma":0.001545185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002239101,"about_ca_topic_score_gemma":0.005159841,"domain_scores_codex":[0.999195,0.000560948,0.00004302109,0.00008096589,0.0000501563,0.00006990515],"domain_scores_gemma":[0.9990271,0.0002163295,0.0002565482,0.000111753,0.0001052331,0.0002829636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9115618,0.008089941,0.0284381,0.001552872,0.005865254,0.0002246115,0.000125697,0.002629869,0.01037015,0.000188096,0.002339245,0.02861422],"study_design_scores_gemma":[0.6372865,0.2496929,0.09258645,0.0003310942,0.008629049,0.0004376294,0.0001225745,0.001395397,0.002614862,0.0002520089,0.006598648,0.00005294946],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990791,0.005288576,0.000402288,0.0001734731,0.00009824253,0.001154006,0.0009240802,0.0000202867,0.001148069],"genre_scores_gemma":[0.9907052,0.001959219,0.001287853,0.0004390707,0.0001169192,0.00103112,0.003393412,0.00001508741,0.001051989],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003038013,"threshold_uncertainty_score":0.01606679,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04028724231131238,"score_gpt":0.3135956297478431,"score_spread":0.2733083874365307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}